Cyrus Harmon
Chief Research Officer at Olema Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Olema Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Olema Pharmaceuticals Inc. June 10, 202577.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 24, 2026 | Olema Pharmaceuticals Inc. | Open-market sale | −12,500 | $11.71 | $146,375 |
| Jul 23, 2026 | Olema Pharmaceuticals Inc. | Open-market sale | −12,500 | $11.58 | $144,750 |
| Jan 20, 2026 | Olema Pharmaceuticals Inc. | Open-market sale | −10,000 | $26.88 | $268,800 |
| Jan 14, 2026 | Olema Pharmaceuticals Inc. | Open-market sale | −3,489 | $29.12 | $101,600 |
| Dec 22, 2025 | Olema Pharmaceuticals Inc. | Open-market sale | −2,881 | $28.53 | $82,195 |
| Sep 18, 2025 | Olema Pharmaceuticals Inc. | Open-market sale | −10,000 | $8.33 | $83,300 |
| Sep 18, 2025 | Olema Pharmaceuticals Inc. | Open-market sale | −3,086 | $8.32 | $25,676 |
| Sep 16, 2025 | Olema Pharmaceuticals Inc. | Open-market sale | −10,000 | $8.04 | $80,400 |
| Sep 16, 2025 | Olema Pharmaceuticals Inc. | Open-market sale | −1,914 | $8.08 | $15,465 |
| Dec 11, 2024 | Olema Pharmaceuticals Inc. | Open-market sale | −7,958 | $8.66 | $68,916 |
| Dec 11, 2024 | Olema Pharmaceuticals Inc. | Open-market sale | −179 | $9.39 | $1,681 |
| Dec 10, 2024 | Olema Pharmaceuticals Inc. | Open-market sale | −8,256 | $9.37 | $77,359 |
| Dec 9, 2024 | Olema Pharmaceuticals Inc. | Grant or award | +29,250 | — | — |
| Jul 30, 2024 | Olema Pharmaceuticals Inc. | Open-market sale | −934 | $15.55 | $14,524 |
| Jul 29, 2024 | Olema Pharmaceuticals Inc. | Open-market sale | −4,066 | $15.58 | $63,348 |
Questions about Cyrus Harmon
What boards is Cyrus Harmon on?
Cyrus Harmon sits on the board of Olema Pharmaceuticals Inc.
How long has Cyrus Harmon served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.